Article Per Year (5 Year)
p-Index From 2021 - 2026
0.888
P-Index
This Author published in this journals
All Journal Narra J Journal of Medical Science; Jurnal Ilmu Medis Rumah Sakit Umum Daerah dr. Zainoel Abidin, Banda Aceh Media Penelitian dan Pengembangan Kesehatan
ENDANG MUTIAWATI, ENDANG
Neurology Department Faculty of Medicine Syiah Kuala University, Banda Aceh, Indonesia
Biochemistry, Genetics & Molecular Biology Decision Sciences, Operations Research & Management Dentistry Environmental Science Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 4 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 4 Documents
Search

 1 
Global prevalence of persistent neuromuscular symptoms and the possible pathomechanisms in COVID-19 recovered individuals: A systematic review and meta-analysis Fajar, Jhonny K.; Ilmawan, Muhammad; Mamada, Sukamto; Mutiawati, Endang; Husnah, Milda; Yusuf, Hanifah; Nainu, Firzan; Sirinam, Salin; Keam, Synat; Ophinni, Youdiil; Rosiello, Francesco; Fahriani, Marhami; Rosa, Sandro GV.
Narra J Vol. 1 No. 3 (2021): December 2021
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v1i3.48

Abstract

This study was conducted to determine the prevalence of prolonged neuromuscular symptoms, including fatigue, anosmia, headache, myalgia, and joint pain in COVID-19 survivors hospitalized with mild, moderate, or severe infections worldwide. The search was conducted up to January 30th, 2021 using three databases (PubMed, Scopus, and Web of Science) to identify potentially eligible studies. Data on study characteristics, follow-up characteristics, and severity of COVID-19 during hospitalization were collected in accordance with PRISMA guidelines. The Newcastle-Ottawa scale was used to assess the quality of relevant articles. The estimated prevalence of specific prolonged neuromuscular symptoms and the association between COVID-19 severity and occurrence of prolonged neuromuscular symptoms was analyzed wherever appropriate. Database search yielded 4,050 articles and 22 articles were included for meta-analysis. The estimated prevalence of prolonged fatigue was recorded in 21.2% (95%CI: 11.9%–34.8%) of 3,730 COVID-19 survivors. Persistent anosmia was recorded in 239 of 2,600 COVID-19 survivors (9.7%, 95%CI: 6.1%–15.2%). In 84 out of 2,412 COVID-19 survivors (8.9%, 95%CI: 3.2%–22.6%), prolonged headache was observed. A total of 53 out of 1,125 COVID-19 patients (5.6%, 95%CI: 2.1%–14.2%) complained of persistent myalgia even after being discharged from the hospital. The prevalence of prolonged joint pain was in 15.4% (95%CI: 8.2%–27.2%) of subjects. Due to data scarcity on COVID-19 severity and prolonged neuromuscular symptoms, association analysis could not be conducted. Widespread concern regarding long-term impacts of COVID-19 was raised after several studies reported prolonged symptoms in COVID-19 survivors. Numerous theories have been proposed to address this concern; however, as the research on this pandemic is still ongoing, no explanation is definitive yet. Therefore, follow-up studies in COVID-19 survivors after recovery from COVID-19 are warranted to determine the pathogenesis of prolonged symptoms. PROSPERO registration: CRD42021242332.
A comparison study of headache characteristics and headache-associated quality-of-life of COVID-19 and non-COVID-19 patients Mutiawati, Endang; Kusuma, Hendrix Indra; Fathima, Raisha; Syahrul, Syahrul; Musadir, Nasrul
Narra J Vol. 2 No. 3 (2022): December 2022
Publisher : Narra Sains Indonesia

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.52225/narra.v2i3.93

Abstract

Headache is prevalent in coronavirus disease 2019 (COVID-19) patients. The main objective of this study was to compare the characteristics of COVID-19-associated headache to non-COVID-19 headache. The quality-of-life (QoL) and its associated determinants between COVID-19 and non-COVID-19 patients were also compared. A cross-sectional study was conducted in Banda Aceh, Indonesia. Headache and QoL were assessed using the International Classification of Headache Disorders, version 3 (ICHD-3), and the 36-item Short Form Health Survey (SF-36), respectively. Factors associated with poor QoL in COVID-19 and non-COVID-19 patients were examined using logistic regression. A total of 356 headache patients were included: 215 COVID-19 and 141 non-COVID-19 patients. Our data suggested that the headache in COVID-19 patients was bilateral; pain centered on one specific area with a pulsating or pressing sensation; pain intensity ranging from moderate to severe; and the frequency ranging from more than twice per week to every day. Non-COVID-19 headache was bilateral; pain centered on one side of the head resembling a migraine with pulsating or pressing sensation; mild to moderate pain intensity; and the frequency of one or two times per month. In COVID-19, low QoL was associated with unemployment status, having non-health-related jobs, having used painkillers to reduce the pain, having long duration of headache, having more frequency of attacks, and having headaches that were worsened by activities or light, and having additional symptom during a headache attach. In non-COVID-19 patients, poor QoL was associated with the use of painkillers, long duration of headache, and having conditions that aggravate the headache. To prevent long-term effects of headache associated with COVID-19, studies exploring the photobiology of headache are  needed, along with the necessity of having standardised guideline on headache prevention.
Studi Nyeri Kepala Paska Vaksinasi COVID-19 pada Petugas di Rumah Sakit Umum Daerah dr. Zainoel Abidin Mutiawati, Endang; Diana; Arief, Teuku Ona
Journal of Medical Science Vol 5 No 2 (2024): Journal of Medical Science
Publisher : LITBANG RSUDZA

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.55572/jms.v5i2.138

Abstract

Nyeri kepala merupakan gejala neurologis yang paling umum terjadi pada lebih dari 50% paska vaksinasi COVID-19. Namun, masih sangat sedikit pengetahuan mengenai karakteristik nyeri kepala paska vaksin COVID-19. Tujuan dari penelitian ini adalah untuk mendeskripsikan karakteristik nyeri kepala paska vaksinasi COVID-19 dan dampaknya terhadap kualitas hidup. Penelitian ini menggunakan desain cross-sectional yang dilakukan di RSUZA dari bulan Mei-September 2023. Sampel penelitian adalah seluruh petugas di RSUZA yang mengalami nyeri kepala paska vaksinasi. Teknik pengambilan sampel menggunakan total sampling dan pengumpulan data menggunakan kuesioner. Data yang dikumpulkan berupa data demografi, jenis vaksin, gejala klinis paska vaksinasi COVID 19, karakteristik nyeri kepala dan kualitas hidup. Nyeri kepala didiagnosis dengan menggunakan karakteristik International Classification of Headache Disorders, version 3 (ICHD-3) dan kualitas hidup dinilai menggunakan instrumen Short Form 36 Health Survey (SF-36). Analisa statistik menggunakan regresi logistik untuk menilai faktor-faktor penentu kualitas hidup yang tidak baik pada subjek paska vaksinasi COVID-19. Sebanyak 97 sampel penelitian paska vaksinasi COVID-19 yang dianalisa didapatkan sebanyak 55,7% berusia 30-39 tahun dan didominasi jenis kelamin perempuan (74,2%). Karakteristik nyeri kepala paska vaksinasi COVID-19 dalam penelitian ini antara lain lokasi bilateral (44,3%), berdenyut (69,1%), intensitas ringan (52,6%), durasi 1 jam (59,8%) dengan frekuensi 1-2 kali setiap bulan (58,8%). Mayoritas sampel penelitian (83,5%) memiliki fungsi fisik yang baik, namun 26,8% memiliki keterbatasan karena masalah fisik dan 35,1% karena masalah emosional. Terdapat 12,4% sampel mengalami kelelahan karena nyeri kepala, 9,3% mengalami kesehatan mental yang tidak baik, 19,6% terganggu fungsi sosial dan 45,4% mengalami gangguan kesehatan secara umum. Karakteristik nyeri kepala yang mempengaruhi kualitas hidup adalah nyeri kepala yang terjadi 1- 4 minggu setelah vaksin COVID-19 memiliki risiko mengalami kualitas hidup yang tidak baik (OR: 0,01, 95%CI: 0,00-0,80, dengan p = 0,039). Kesimpulan, karakteristik nyeri kepala paska vaksinasi berupa lokasi bilateral, berdenyut dan intensitas ringan, namun masih diperlukan penelitian lanjutan dengan jumlah sampel yang lebih besar.
SEVERE DIABETIC NEUROPATHY RESULTS IN POOR SLEEP QUALITY IN TYPE-2 DIABETES MELLITUS PATIENTS Atika, Siti; Mutiawati, Endang; Farida, Farida; Suhanda, Rachmad
Media Penelitian dan Pengembangan Kesehatan Vol. 35 No. 3 (2025): MEDIA PENELITIAN DAN PENGEMBANGAN KESEHATAN
Publisher : Poltekkes Kemenkes Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.34011/jmp2k.v35i3.3102

Abstract

Diabetes mellitus merupakan kelainan metabolisme kronis yang dapat menyebabkan komplikasi seperti neuropati diabetik. Neuropati diabetik dapat berimbas pada penurunan kualitas hidup secara substansial akibat gangguan tidur yang disebabkannya. Penelitian dilakukan untuk mengetahui hubungan keparahan neuropati diabetik dengan kualitas tidur pasien diabetes mellitus tipe 2. Penelitian analitik obervasional dengan desain cross-sectional. Subjek penelitian diambil berdasarkan teknik consecutive sampling pada pasien neuropati diabetik yang dirawat jalan di RSUD dr. Zainoel Abidin Banda Aceh pada September–November 2024. 69 responden terpilih sebagai sampel penelitian. Penilaian derajat keparahan neuropati diabetik dilakukan menggunakan Total Neuropathy Score (TNS) dan Neuropathy Symptom Score (NSS). Kualitas tidur dinilai menggunakan Pittsburgh Sleep Quality Index (PSQI). Hasil menunjukkan adanya korelasi antara keparahan neuropati diabetik berdasarkan TNS (r=0,492; p-value=0,000) dan NSS (r=0,721; p-value=0,000) dengan kualitas tidur pasien. Skor TNS menunjukkan hubungan yang kuat, dan skor NSS menunjukkan hubungan yang sangat kuat, dengan arah positif terhadap kualitas tidur pasien dengan neuropati diabetik. Hal ini menunjukkan bahwa peningkatan keparahan neuropati menyebabkan peningkatan skor kualitas tidur, yang bermakna sebagai penurunan kualitas tidur pasien dengan neuropati diabetik.
Co-Authors Arief, Teuku Ona Atika, Siti Diana Fahriani, Marhami Fajar, Jhonny K. Farida Farida Fathima, Raisha Firzan Nainu Hanifah Yusuf Husnah, Milda Ilmawan, Muhammad Keam, Synat KUSUMA, HENDRIX INDRA Mamada, Sukamto Ophinni, Youdiil Rachmad Suhanda Rosa, Sandro GV. Rosiello, Francesco Sirinam, Salin Syahrul Syahrul